English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 114 | Tables: 115 | Pharma & Healthcare
The global FPR1 Inhibitor market was valued at US$ 44.47 million in 2025 and is anticipated to reach US$ 55.6 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on FPR1 Inhibitor competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of FPR1 inhibitors reached 3,076 grams, with an average selling price of US$14 per mg.
FPR1 inhibitor is a compound or substance used to inhibit the activity of FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 inhibitors bind to FPR1 and block its signaling pathway, thereby inhibiting its related biological responses. These inhibitors are often used in scientific research to explore the role of FPR1 in physiological and pathological processes and may serve as potential drug targets for the development of disease treatments.
The FPR1 inhibitor market has shown a steady development trend in recent years. With in-depth research on the biological functions of FPR1 (Formyl Peptide Receptor 1), its key role in inflammatory response, cell migration, cancer development and other processes has been gradually revealed, which has promoted the development and application of FPR1 inhibitors. FPR1 inhibitors are mainly used in scientific research experiments, especially in drug discovery and mechanism research, playing an important role. They provide researchers with tools to regulate FPR1 function to gain insights into related physiological processes and develop novel treatments. In summary, the FPR1 inhibitor market has broad development prospects and huge market potential.
This report delivers a comprehensive overview of the global FPR1 Inhibitor market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding FPR1 Inhibitor. The FPR1 Inhibitor market size, estimates, and forecasts are provided in terms of sales volume (g) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global FPR1 Inhibitor market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist FPR1 Inhibitor manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Bio-Techne
Abcam
ApexBio Technology
TargetMol Chemicals
GLPBio
ProbeChem Biochemicals
MedChemExpress
Segment by Type
FPR1 Antagonists
Indirect Inhibitors
Antibody Blockers
Others
by Application
Pharma/Biotech
Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for FPR1 Inhibitor manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines FPR1 Inhibitor sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 FPR1 Inhibitor Market Overview
1.1 Product Definition
1.2 FPR1 Inhibitor by Type
1.2.1 Global FPR1 Inhibitor Market Value by Type: 2025 vs 2032
1.2.2 FPR1 Antagonists
1.2.3 Indirect Inhibitors
1.2.4 Antibody Blockers
1.2.5 Others
1.3 FPR1 Inhibitor by Application
1.3.1 Global FPR1 Inhibitor Market Value by Application: 2025 vs 2032
1.3.2 Pharma/Biotech
1.3.3 Research
1.3.4 Other
1.4 Global FPR1 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global FPR1 Inhibitor Revenue 2021–2032
1.4.2 Global FPR1 Inhibitor Sales 2021–2032
1.4.3 Global FPR1 Inhibitor Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 FPR1 Inhibitor Market Competition by Manufacturers
2.1 Global FPR1 Inhibitor Sales Market Share by Manufacturers (2021–2026)
2.2 Global FPR1 Inhibitor Revenue Market Share by Manufacturers (2021–2026)
2.3 Global FPR1 Inhibitor Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of FPR1 Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of FPR1 Inhibitor, Product Types and Applications
2.7 Global Key Manufacturers of FPR1 Inhibitor, Date of Entry into the Industry
2.8 Global FPR1 Inhibitor Market Competitive Situation and Trends
2.8.1 Global FPR1 Inhibitor Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global FPR1 Inhibitor Players Market Share by Revenue
2.8.3 Global FPR1 Inhibitor Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FPR1 Inhibitor Market Scenario by Region
3.1 Global FPR1 Inhibitor Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global FPR1 Inhibitor Sales by Region: 2021–2032
3.2.1 Global FPR1 Inhibitor Sales by Region: 2021–2026
3.2.2 Global FPR1 Inhibitor Sales by Region: 2027–2032
3.3 Global FPR1 Inhibitor Revenue by Region: 2021–2032
3.3.1 Global FPR1 Inhibitor Revenue by Region: 2021–2026
3.3.2 Global FPR1 Inhibitor Revenue by Region: 2027–2032
3.4 North America FPR1 Inhibitor Market Facts & Figures by Country
3.4.1 North America FPR1 Inhibitor Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America FPR1 Inhibitor Sales by Country (2021–2032)
3.4.3 North America FPR1 Inhibitor Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe FPR1 Inhibitor Market Facts & Figures by Country
3.5.1 Europe FPR1 Inhibitor Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe FPR1 Inhibitor Sales by Country (2021–2032)
3.5.3 Europe FPR1 Inhibitor Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FPR1 Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific FPR1 Inhibitor Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific FPR1 Inhibitor Sales by Region (2021–2032)
3.6.3 Asia Pacific FPR1 Inhibitor Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America FPR1 Inhibitor Market Facts & Figures by Country
3.7.1 Latin America FPR1 Inhibitor Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America FPR1 Inhibitor Sales by Country (2021–2032)
3.7.3 Latin America FPR1 Inhibitor Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa FPR1 Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa FPR1 Inhibitor Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa FPR1 Inhibitor Sales by Country (2021–2032)
3.8.3 Middle East and Africa FPR1 Inhibitor Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FPR1 Inhibitor Sales by Type (2021–2032)
4.1.1 Global FPR1 Inhibitor Sales by Type (2021–2026)
4.1.2 Global FPR1 Inhibitor Sales by Type (2027–2032)
4.1.3 Global FPR1 Inhibitor Sales Market Share by Type (2021–2032)
4.2 Global FPR1 Inhibitor Revenue by Type (2021–2032)
4.2.1 Global FPR1 Inhibitor Revenue by Type (2021–2026)
4.2.2 Global FPR1 Inhibitor Revenue by Type (2027–2032)
4.2.3 Global FPR1 Inhibitor Revenue Market Share by Type (2021–2032)
4.3 Global FPR1 Inhibitor Price by Type (2021–2032)
5 Segment by Application
5.1 Global FPR1 Inhibitor Sales by Application (2021–2032)
5.1.1 Global FPR1 Inhibitor Sales by Application (2021–2026)
5.1.2 Global FPR1 Inhibitor Sales by Application (2027–2032)
5.1.3 Global FPR1 Inhibitor Sales Market Share by Application (2021–2032)
5.2 Global FPR1 Inhibitor Revenue by Application (2021–2032)
5.2.1 Global FPR1 Inhibitor Revenue by Application (2021–2026)
5.2.2 Global FPR1 Inhibitor Revenue by Application (2027–2032)
5.2.3 Global FPR1 Inhibitor Revenue Market Share by Application (2021–2032)
5.3 Global FPR1 Inhibitor Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck FPR1 Inhibitor Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bio-Techne FPR1 Inhibitor Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam FPR1 Inhibitor Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 ApexBio Technology
6.4.1 ApexBio Technology Company Information
6.4.2 ApexBio Technology Description and Business Overview
6.4.3 ApexBio Technology FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ApexBio Technology FPR1 Inhibitor Product Portfolio
6.4.5 ApexBio Technology Recent Developments/Updates
6.5 TargetMol Chemicals
6.5.1 TargetMol Chemicals Company Information
6.5.2 TargetMol Chemicals Description and Business Overview
6.5.3 TargetMol Chemicals FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 TargetMol Chemicals FPR1 Inhibitor Product Portfolio
6.5.5 TargetMol Chemicals Recent Developments/Updates
6.6 GLPBio
6.6.1 GLPBio Company Information
6.6.2 GLPBio Description and Business Overview
6.6.3 GLPBio FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GLPBio FPR1 Inhibitor Product Portfolio
6.6.5 GLPBio Recent Developments/Updates
6.7 ProbeChem Biochemicals
6.7.1 ProbeChem Biochemicals Company Information
6.7.2 ProbeChem Biochemicals Description and Business Overview
6.7.3 ProbeChem Biochemicals FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ProbeChem Biochemicals FPR1 Inhibitor Product Portfolio
6.7.5 ProbeChem Biochemicals Recent Developments/Updates
6.8 MedChemExpress
6.8.1 MedChemExpress Company Information
6.8.2 MedChemExpress Description and Business Overview
6.8.3 MedChemExpress FPR1 Inhibitor Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 MedChemExpress FPR1 Inhibitor Product Portfolio
6.8.5 MedChemExpress Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FPR1 Inhibitor Industry Chain Analysis
7.2 FPR1 Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FPR1 Inhibitor Production Mode & Process Analysis
7.4 FPR1 Inhibitor Sales and Marketing
7.4.1 FPR1 Inhibitor Sales Channels
7.4.2 FPR1 Inhibitor Distributors
7.5 FPR1 Inhibitor Customer Analysis
8 FPR1 Inhibitor Market Dynamics
8.1 FPR1 Inhibitor Industry Trends
8.2 FPR1 Inhibitor Market Drivers
8.3 FPR1 Inhibitor Market Challenges
8.4 FPR1 Inhibitor Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global FPR1 Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global FPR1 Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global FPR1 Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global FPR1 Inhibitor Sales (g) of Key Manufacturers (2021–2026)
Table 5. Global FPR1 Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global FPR1 Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global FPR1 Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market FPR1 Inhibitor Average Price (US$/mg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of FPR1 Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of FPR1 Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of FPR1 Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FPR1 Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on FPR1 Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global FPR1 Inhibitor Sales by Region (g), 2021–2026
Table 18. Global FPR1 Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global FPR1 Inhibitor Sales by Region (g), 2027–2032
Table 20. Global FPR1 Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global FPR1 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global FPR1 Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global FPR1 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global FPR1 Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America FPR1 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America FPR1 Inhibitor Sales by Country (g), 2021–2026
Table 27. North America FPR1 Inhibitor Sales by Country (g), 2027–2032
Table 28. North America FPR1 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America FPR1 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe FPR1 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe FPR1 Inhibitor Sales by Country (g), 2021–2026
Table 32. Europe FPR1 Inhibitor Sales by Country (g), 2027–2032
Table 33. Europe FPR1 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe FPR1 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific FPR1 Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific FPR1 Inhibitor Sales by Region (g), 2021–2026
Table 37. Asia Pacific FPR1 Inhibitor Sales by Region (g), 2027–2032
Table 38. Asia Pacific FPR1 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific FPR1 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America FPR1 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America FPR1 Inhibitor Sales by Country (g), 2021–2026
Table 42. Latin America FPR1 Inhibitor Sales by Country (g), 2027–2032
Table 43. Latin America FPR1 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America FPR1 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa FPR1 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa FPR1 Inhibitor Sales by Country (g), 2021–2026
Table 47. Middle East and Africa FPR1 Inhibitor Sales by Country (g), 2027–2032
Table 48. Middle East and Africa FPR1 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa FPR1 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global FPR1 Inhibitor Sales (g) by Type (2021–2026)
Table 51. Global FPR1 Inhibitor Sales (g) by Type (2027–2032)
Table 52. Global FPR1 Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global FPR1 Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global FPR1 Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global FPR1 Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global FPR1 Inhibitor Price (US$/mg) by Type (2021–2026)
Table 59. Global FPR1 Inhibitor Price (US$/mg) by Type (2027–2032)
Table 60. Global FPR1 Inhibitor Sales (g) by Application (2021–2026)
Table 61. Global FPR1 Inhibitor Sales (g) by Application (2027–2032)
Table 62. Global FPR1 Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global FPR1 Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global FPR1 Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global FPR1 Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global FPR1 Inhibitor Price (US$/mg) by Application (2021–2026)
Table 69. Global FPR1 Inhibitor Price (US$/mg) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 73. Merck FPR1 Inhibitor Product
Table 74. Merck Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 78. Bio-Techne FPR1 Inhibitor Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 83. Abcam FPR1 Inhibitor Product
Table 84. Abcam Recent Developments/Updates
Table 85. ApexBio Technology Company Information
Table 86. ApexBio Technology Description and Business Overview
Table 87. ApexBio Technology FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 88. ApexBio Technology FPR1 Inhibitor Product
Table 89. ApexBio Technology Recent Developments/Updates
Table 90. TargetMol Chemicals Company Information
Table 91. TargetMol Chemicals Description and Business Overview
Table 92. TargetMol Chemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 93. TargetMol Chemicals FPR1 Inhibitor Product
Table 94. TargetMol Chemicals Recent Developments/Updates
Table 95. GLPBio Company Information
Table 96. GLPBio Description and Business Overview
Table 97. GLPBio FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 98. GLPBio FPR1 Inhibitor Product
Table 99. GLPBio Recent Developments/Updates
Table 100. ProbeChem Biochemicals Company Information
Table 101. ProbeChem Biochemicals Description and Business Overview
Table 102. ProbeChem Biochemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 103. ProbeChem Biochemicals FPR1 Inhibitor Product
Table 104. ProbeChem Biochemicals Recent Developments/Updates
Table 105. MedChemExpress Company Information
Table 106. MedChemExpress Description and Business Overview
Table 107. MedChemExpress FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 108. MedChemExpress FPR1 Inhibitor Product
Table 109. MedChemExpress Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. FPR1 Inhibitor Distributors List
Table 113. FPR1 Inhibitor Customers List
Table 114. FPR1 Inhibitor Market Trends
Table 115. FPR1 Inhibitor Market Drivers
Table 116. FPR1 Inhibitor Market Challenges
Table 117. FPR1 Inhibitor Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of FPR1 Inhibitor
Figure 2. Global FPR1 Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global FPR1 Inhibitor Market Share by Type: 2025 & 2032
Figure 4. FPR1 Antagonists Product Picture
Figure 5. Indirect Inhibitors Product Picture
Figure 6. Antibody Blockers Product Picture
Figure 7. Others Product Picture
Figure 8. Global FPR1 Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 9. Global FPR1 Inhibitor Market Share by Application: 2025 & 2032
Figure 10. Pharma/Biotech
Figure 11. Research
Figure 12. Other
Figure 13. Global FPR1 Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global FPR1 Inhibitor Market Size (US$ Million), 2021–2032
Figure 15. Global FPR1 Inhibitor Sales (g), 2021–2032
Figure 16. Global FPR1 Inhibitor Average Price (US$/mg), 2021–2032
Figure 17. FPR1 Inhibitor Report Years Considered
Figure 18. FPR1 Inhibitor Sales Share by Manufacturers in 2025
Figure 19. Global FPR1 Inhibitor Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global FPR1 Inhibitor Players: Market Share by Revenue in FPR1 Inhibitor in 2025
Figure 21. FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America FPR1 Inhibitor Sales Market Share by Country (2021–2032)
Figure 24. North America FPR1 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 25. United States FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe FPR1 Inhibitor Sales Market Share by Country (2021–2032)
Figure 28. Europe FPR1 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 29. Germany FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific FPR1 Inhibitor Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific FPR1 Inhibitor Revenue Market Share by Region (2021–2032)
Figure 36. China FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America FPR1 Inhibitor Sales Market Share by Country (2021–2032)
Figure 44. Latin America FPR1 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 45. Mexico FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa FPR1 Inhibitor Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa FPR1 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 51. Turkey FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE FPR1 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of FPR1 Inhibitor by Type (2021–2032)
Figure 55. Global Revenue Market Share of FPR1 Inhibitor by Type (2021–2032)
Figure 56. Global FPR1 Inhibitor Price (US$/mg) by Type (2021–2032)
Figure 57. Global Sales Market Share of FPR1 Inhibitor by Application (2021–2032)
Figure 58. Global Revenue Market Share of FPR1 Inhibitor by Application (2021–2032)
Figure 59. Global FPR1 Inhibitor Price (US$/mg) by Application (2021–2032)
Figure 60. FPR1 Inhibitor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
